IBM 10-Qquarter ended 2026-06-30
Confluent lifted software growth but reduced liquidity; delayed IBM Z deals and weaker Transaction Processing weighed on results.
Filed 2026-07-22 18:14 ET
Key figures · Q2 FY2026 · period ended 2026-06-30
- Revenue$17.2BYoY +1.1%QoQ +7.8%
- Operating income— Not reported
- Net income$2.2BYoY −1.3%QoQ +78.0%
- Total assets$152.1BYoY +2.4%QoQ −2.6%
- Total debt$62.0BYoY −3.4%QoQ −6.6%
How total debt adds up Long-term debt $56,212M + Short-term debt $5,775M Total debt $61,987M Lines as the filer presents them on its balance sheet.
- Shareholders' equity$34.5BYoY +25.2%QoQ +4.5%
- Tangible book value−$54.1BYoY −3.5%QoQ +4.0%
How this filing reads
- Health0.0H1 free cash flow was $4.76B, while cash fell to $7.17B against $62.0B debt.
- Momentum−0.3Q2 revenue grew 1.1%, while GAAP earnings fell 1.3% and gross margin declined 1.0 point.
- Outlook−0.2IBM Z revenue fell 42%, with delayed deals and second-half demand still unconverted.
Executive Summary
IBM’s software-led transformation advanced in Q2, but acquisition-supported growth masked weakness in mainframes and transactional software: revenue rose 1.1%, while GAAP earnings slipped and gross margin narrowed. Confluent strengthened IBM’s data platform, and Consulting improved profitability despite broadly flat revenue, but management acknowledged results fell short of expectations. The acquisition substantially reduced liquidity, while rising operating cash flow did not translate into growth in IBM-defined free cash flow. Investors must weigh recurring-software expansion against acquisition execution, delayed infrastructure demand, and substantial quantum investment commitments.
Key Financial Highlights
| Metric | Q2 2026 | H1 2026 / balance sheet at 6/30/2026 | Investor interpretation |
|---|---|---|---|
| Revenue | $17.2B; +1.1% Y/Y | $33.1B; +5.0% Y/Y | Growth slowed sharply in Q2. |
| Gross profit / margin | $9.91B / 57.7%; margin down 1.0 percentage point | $18.9B / 57.0%; margin broadly flat | Revenue growth did not protect quarterly margins. |
| GAAP net income / diluted EPS | $2.17B / $2.27; earnings down 1.3% | $3.38B / $3.55; earnings up 4.1% | Quarterly earnings lagged revenue. |
| Operating earnings, non-GAAP | $2.79B; +5.3% Y/Y | $4.61B; +11% Y/Y | Acquisition and retirement costs explain part of the gap with GAAP earnings above. |
| OCF | — | $7.77B; +28% Y/Y | Cash exceeded same-period net income, but IBM-defined FCF was broadly flat. |
| Total assets | — | $152B; broadly flat | Acquisitions changed asset composition more than size. |
| Total equity / tangible common equity | — | $34.5B / $(54.0)B | Goodwill and intangibles exceed equity. |
| Total debt / cash and equivalents | — | $62.0B / $7.17B; cash down from $13.6B | Acquisition funding reduced cash flexibility. |
- Cash conversion: OCF minus reported net capital expenditures of $0.743B equals $7.02B; IBM-defined FCF was $4.76B, broadly flat Y/Y. Management cited higher inventory, cash taxes and net interest as offsets to operating improvements; financing receivables declined to $13.8B from $16.2B.
- Asset quality: goodwill reached $74.6B and net intangibles $14.0B following Confluent; acquisition value depends heavily on future earnings rather than tangible assets.
- Capital allocation: H1 dividends consumed $3.17B. Stock-based compensation rose 19% to $1.00B, while outstanding shares increased to ≈942M from 937M, adding dilution.
- Financial volatility: H1 foreign-exchange gains of $0.435B accompanied derivative losses of $(0.540)B; their offsetting direction makes either item alone a misleading earnings signal.
Business Developments
- Software expansion: Q2 Software revenue rose 5.1% to $7.76B, representing 45% of consolidated revenue. Data growth primarily reflected Confluent, while Hybrid Cloud expanded and Transaction Processing declined; ≈80% recurring revenue supports predictability, but headline growth is not purely organic.
- Confluent acquisition: completed 3/17/2026 for $11.6B total consideration, adding $7.24B goodwill and $3.83B identifiable intangibles; IBM also settled $1.10B of acquired convertible-note debt. The provisional allocation concentrates execution risk in the data-platform strategy.
- Consulting productivity: Q2 segment profit increased 15% to $0.647B despite broadly flat revenue. H1 signings rose 6.8% to $10.4B, supporting potential growth without yet demonstrating stronger revenue conversion.
- Infrastructure and quantum: IBM Z revenue fell 42% as launch comparisons and delayed large deals weighed on demand; inventory was built for expected second-half demand. Management announced more than $10B of quantum investment over five years, including a U.S. wafer foundry supported by $1B of incentives and $1B of IBM cash.
Risk Assessment
- Demand and execution: Q2 Infrastructure revenue fell 7.4%; shifted client priorities, supply constraints and delayed mainframe deals could also prolong Transaction Processing weakness.
- Acquisition and valuation: Confluent’s large goodwill allocation increases exposure to integration failure and impairment if expected growth disappoints.
- Liquidity and funding: the working-capital deficit widened to $7.51B from $1.71B; $10B of undrawn credit facilities provides backup, but acquisitions, dividends and investment compete for cash.
- Innovation and competition: AI, hybrid-cloud and quantum investment may fail to generate sufficient commercial returns, while cybersecurity incidents or supplier disruption could impair delivery and customer confidence.
- Financial exposures: currency, pensions and customer credit can alter earnings and cash independently of operating demand; H1 retirement-plan costs increased to $0.643B from $0.482B.
A 10-Q does not have to restate the risk factors in the annual report. Full list: the company's 10-Ks on SEC.
Strategic Outlook and Investor Actionables
IBM’s thesis is that recurring software, Confluent and productivity gains can offset infrastructure cyclicality while quantum creates longer-term opportunity. Success requires converting these investments into growth without sacrificing cash flexibility.
- Software integration: Data revenue reached $1.78B and software annual recurring revenue $24.6B. Sustained expansion alongside improving Software profitability would support Confluent’s economics; stalled growth or impairment would undermine them.
- Mainframe recovery: IBM Z declined 42%, with Q2 Infrastructure revenue $3.84B. Later filings should show delayed demand converting into revenue and inventory normalizing; continued weakness would challenge management’s second-half expectations.
- Quantum commercialization: management committed more than $10B over five years. Subsequent filings should demonstrate foundry progress and commercial deployment; delays or expanding commitments without adoption would weaken the return case.
- Cash capacity: IBM-defined H1 FCF was $4.76B against $3.17B of dividends. Rising FCF and stabilized liquidity would support investment capacity; further cash depletion or borrowing would tighten the funding trade-off.
Not present in this filing: Item 3, Quantitative and Qualitative Disclosures About Market Risk; Part II Item 1A, Risk Factors.
Figures are computed from the filing's XBRL data; the summary and scores are written by an AI model reading the filing.
Model 006 · prompt bdad6d7239